Tebipenem Pivoxil – Oral Products
| Pathogen | Minimum Inhibitory Concentrations (mcg/mL) | Disk Diffusionb (zone diameters in mm) | ||||
|---|---|---|---|---|---|---|
S | I | R | S | I | R | |
| Enterobacteralesa | ≤0.12 | 0.25 | ≥ 0.5 | ≥29 | 24-28 | ≤23 |
S = Susceptible; I = Intermediate; R = Resistant
- For Enterobacterales, clinical efficacy was shown for Escherichia coli, Enterobacter cloacae complex, Klebsiella pneumoniae, and Klebsiella oxytoca in patients with complicated urinary tract infections (cUTI).
- For disk diffusion, use paper disks impregnated with 10 mcg tebipenem.